Anti-Cancer Drugs

About Anti-Cancer Drugs

Anti-Cancer Drugs is a peer-reviewed academic journal published by Lippincott Williams & Wilkins.

Editorial Perspective & Metric Analysis

Based on current metadata, Anti-Cancer Drugs maintains a standard position in the GB academic market. With an impact factor of 1.73, it remains a steady venue for researchers in its specific sub-fields.

ISSN (Print) 0959-4973
ISSN (Online) 1473-5741
Publisher Lippincott Williams & Wilkins
Country United Kingdom
APC / Cost Inquire with Publisher
About Anti-Cancer Drugs

Anti-Cancer Drugs is a peer-reviewed academic journal published by Lippincott Williams & Wilkins.

Anti-Cancer Drugs is published by Lippincott Williams & Wilkins from GB as a journal. It has published 5,068 works to date, attracting 106,882 citations across the literature. The journal carries an h-index of 113, reflecting both depth of catalog and sustained citation impact. Recent publishing activity centers on Cancer therapeutics and mechanisms, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies.
Links
Frequently Asked Questions about Anti-Cancer Drugs

The current impact factor of Anti-Cancer Drugs is 1.728.

No, Anti-Cancer Drugs is not an open access journal.

Anti-Cancer Drugs is published by Lippincott Williams & Wilkins.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Impact Factor
1.728
Current Impact Factor
Historical Trend
Initial data points only
Impact Factors by Year
Year Value Source
2025 1.728 CiteScore (Scopus)

Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Journal at a Glance
5,068
Total Works
106,882
Total Citations
113
h-index
1.74
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Anti-Cancer Drugs most frequently publishes, ranked by article volume.

  1. Cancer therapeutics and mechanisms
    Biochemistry, Genetics and Molecular Biology
    529 works
  2. Cancer Treatment and Pharmacology
    Medicine
    523 works
  3. Colorectal Cancer Treatments and Studies
    Medicine
    410 works
  4. Lung Cancer Treatments and Mutations
    Medicine
    386 works
  5. Lung Cancer Research Studies
    Medicine
    315 works
  6. Drug Transport and Resistance Mechanisms
    Medicine
    238 works
  7. HER2/EGFR in Cancer Research
    Medicine
    202 works
  8. Cancer-related Molecular Pathways
    Medicine
    187 works
Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S158028025

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now